Uganda has begun a clinical trial of a vaccine against the Sudan strain of Ebola following an outbreak that has killed one nurse in the east African country.

Uganda has begun a trial vaccination programme for the strain of Ebola viral infection that is behind Sudan's latest outbreak, according to the World Health Organization (WHO), while the number of confirmed cases has risen to three.

Confirmation of Ebola Sudan in Uganda poses a high risk of further spread owing to the index patient's movements across multiple districts and healthcare facilities, the WHO said. It added that rapid containment is critical, because of Kampala's dense population and Mbale's location near the border with Kenya.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! Did you know it's

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week

Sudan virus (SUDV) can infect people to cause Sudan virus disease (SVD). Right now, an outbreak of SVD has been detected in Uganda. | Clinical And Molecular Dx

If proven effective, vaccine will further strengthen measures to protect communities from future outbreaks,’ says regional director of world health body - Anadolu Ajansı

Makerere University, the Uganda Virus Research Institute and the WHO got the Ebola vaccine trial ready for dosing in just four days.

A Ugandan doctor prepares to vaccinate the contact of a patient who had tested positive, during the launch of the vaccination for the Sudan strain of Ebola virus with a trial vaccine at the Mulago Guest House (Isolation centre) in Kampala,